Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure

Antzeko izenburuak

• Is it true that PMX-DHP can improve lung oxygenation?
  nork: Ikeda, T, et al.
  Argitaratua: (2003)
• The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
  nork: Ikeda, T, et al.
  Argitaratua: (2007)
• Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
  nork: Ikeda, T, et al.
  Argitaratua: (2005)
• Effect of PMX-DHP according to differences in infection site
  nork: Ikeda, T, et al.
  Argitaratua: (2001)
• Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
  nork: Kase, Y, et al.
  Argitaratua: (2009)